Update Breast Cancer 2023 Part 2 – Advanced-Stage Breast Cancer
Geburtshilfe und Frauenheilkunde · 01.06.2023 · 83 (06) · 664-672
DOI: 10.1055/a-2074-0125 ↗Kurz gefasst
Fachartikel in der Zeitschrift Geburtshilfe und Frauenheilkunde, erschienen am 01.06.2023. Verfasst von Michael P Lux und 29 weiteren Autor:innen. Beteiligte Einrichtung: Klinik für Gynäkologie und Geburtshilfe, Frauenklinik St. Louise, Paderborn, St. Josefs-Krankenhaus, Salzkotten, St. Vincenz Krankenhaus GmbH, Paderb…. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
In recent years, a number of new therapies have led to advances in the treatment of patients with advanced breast carcinoma. These substances are mainly CDK4/6 inhibitors and other substances that can overcome endocrine resistance, oral selective estrogen receptor degraders, antibody drug conjugates (ADCs), and PARP inhibitors. This review summarizes and evaluates the latest study results that have been published in recent months. This includes the overall survival data of the Destiny-Breast03 study, the first analysis of the CAPItello-291 study, the comparison of CDK4/6 inhibitor treatment with chemotherapy in the first line of therapy (RIGHT Choice study), the first analysis of the Destiny-Breast02 study in the treatment setting after T-DM1 treatment, and the first analysis of the Serena-2 study. Most of these studies have the potential to significantly change the therapeutic landscape for patients with advanced breast carcinoma and show that the continued rapid development of new therapies is always producing new results.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Klinik für Gynäkologie und Geburtshilfe, Frauenklinik St. Louise, Paderborn, St. Josefs-Krankenhaus, Salzkotten, St. Vincenz Krankenhaus GmbH, Paderborn, Germany.
- Department of Gynecology and Obstetrics, Ulm University Hospital, Ulm, Germany.
- Department of Gynecology and Obstetrics, University Hospital Düsseldorf, Düsseldorf, Germany.
- Onkologie Aschaffenburg, Aschaffenburg, Germany.
- Department of Gynecology, Hamburg-Eppendorf University Medical Center, Hamburg, Germany.
- Gynäkologie und Geburtshilfe, Diakonissen-Stiftungs-Krankenhaus Speyer, Speyer, Germany.
Zitieren
APA
Lux, M. P., Hartkopf, A. D., Fehm, T. N., Welslau, M., Müller, V., Schütz, F., Fasching, P. A., Janni, W., Witzel, I., Thomssen, C., Beierlein, M., Belleville, E., Untch, M., Thill, M., Tesch, H., Ditsch, N., Aktas, B., Banys-Paluchowski, M., Kolberg-Liedtke, C., …, & Stickeler, E. (2023). Update Breast Cancer 2023 Part 2 – Advanced-Stage Breast Cancer. Geburtshilfe und Frauenheilkunde, 83(06), 664-672. https://doi.org/10.1055/a-2074-0125
Vancouver
Lux MP, Hartkopf AD, Fehm TN, Welslau M, Müller V, Schütz F, et al. Update Breast Cancer 2023 Part 2 – Advanced-Stage Breast Cancer. Geburtshilfe und Frauenheilkunde. 2023;83(06):664-672. doi:10.1055/a-2074-0125
BibTeX
@article{Lux2023,
author = {Lux, Michael P and Hartkopf, Andreas D and Fehm, Tanja N and Welslau, Manfred and Müller, Volkmar and Schütz, Florian and Fasching, Peter A and Janni, Wolfgang and Witzel, Isabell and Thomssen, Christoph and Beierlein, Milena and Belleville, Erik and Untch, Michael and Thill, Marc and Tesch, Hans and Ditsch, Nina and Aktas, Bahriye and Banys-Paluchowski, Maggie and Kolberg-Liedtke, Cornelia and Wöckel, Achim and Kolberg, Hans-Christian and Harbeck, Nadia and Bartsch, Rupert and Schneeweiss, Andreas and Ettl, Johannes and Würstlein, Rachel and Krug, David and Taran, Florin-Andrei and Lüftner, Diana and Stickeler, Elmar},
title = {Update Breast Cancer 2023 Part 2 – Advanced-Stage Breast Cancer},
journal = {Geburtshilfe und Frauenheilkunde},
year = {2023},
volume = {83},
number = {06},
pages = {664--672},
doi = {10.1055/a-2074-0125}
}
EUVIMED